1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1600 Search
  5. Art Unit 1699
  6. Examiner Bausch

Examiner Bausch Sarae L

1699-BAUSCH-SARAE-L

Employment Information

Art Unit:1699 — Drug, bio-affecting and body treating compositions
Group:1600 Search — Search and Classification
Classes: 435 — Chemistry: molecular biology and microbiology
424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
506 — Combinatorial chemistry technology: method, library, apparatus
536 — Organic compounds -- part of the class 532-570 series
436 — Chemistry: analytical and immunological testing
702 — Data processing: measuring, calibrating, or testing
Phone:(571) 272-2912
Email:sarae.bausch@uspto.gov
Location:VA 22314
Title:Pat Examnr
Service:22 years
Grade:GS-14

Grant Rate and Difficulty Ranking

91
3-Year Grant rate: 28% over 172 cases
Difficulty: Extremely Hard
Difficulty Percentile: 91st

With Examiner Bausch, you have a 28% chance of getting an issued patent by 3 years after the first office action. Examiner Bausch is an extremely hard examiner and in the 91st percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Bausch, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1699

Examiner Bausch's grant rate is lower than that of Art Unit 1699 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Bausch 2.2
Art Unit 1699 1.6

Interview Benefit

Grant Rate without Interview

Examiner Bausch has granted 34 of 138 cases without any applicant-requested interviews for a grant rate of 25%.

Grant Rate with Interview

Examiner Bausch has granted 15 of 34 cases with at least one applicant-requested interview for a grant rate of 44%.

Interview Benefit

With Examiner Bausch, conducting an interview increases your chance of getting a patent granted by 76%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18063257 Neuroendocrine Tumors Rejection information available with a Premium Stats subscription. See our pricing. Patented View
17762065 Sudden Cardiac Death Susceptibility Detection Kit Based On Insertion/deletion Polymorphic Site Of Cox10 Gene Abandoned View
18082464 Biomarkers For Predicting Responsiveness To Mek Inhibitor Monotherapy And Combination Therapy Abandoned View
16973361 Quantitative Pcr Probe Abandoned View
17760411 Analysis Method For Increasing Susceptibility To Sorafenib Treatment In Hepatocellular Carcinoma Abandoned View
17571248 Method Of Diagnosing Bladder Cancer Patented View
17913418 Application Of Red Blood Cell Nucleic Acid In Identifying Tumor Mutation Types Abandoned View
17795428 Methods For Predicting Ixabepilone Responsiveness In Cancer Patients Abandoned View
17796156 Dimerization Assay Abandoned View
17438288 Microrna Regulatory Network As Biomarkers Of Seizure In Patients With Spontaneous Intracerebral Hemorrhage Patented View
17041534 Post-Surgical Risk Stratification Based On Pde4d Variant Expression, Selected According To Tmprss2-Erg Fusion Status, And Post-Surgical Clinical Variables Patented View
17812591 Prognosis Method For Renal Cell Cancer Abandoned View
17282630 Detection And Analysis Of Cells Patented View
17041993 Identification Of Epigenetic Alterations In Dna Isolated From Exosomes Patented View
17582510 Genomic Diagnostic Method And Kit To Diagnose Early Esophageal Cancer And Barretts Esophagus Abandoned View
17814400 Classifying Tumors Using Both Genetics And Collagen Expression To Improve Drug Targeting Abandoned View
17773288 Methods For Predicting Responsiveness Of Prostate Cancer Patients To Parp Inhibitors Abandoned View
17769340 Detection Of A Target Polynucleotide Abandoned View
17466786 Methods And Compositions For Predicting And/or Monitoring Cardiovascular Disease And Treatments Therefor Abandoned View
17766957 A Gene Associated With Human Reading Performance Abandoned View
17764642 Methods Of Determining Whether Patients Suffering From Acute Myeloid Leukemia Will Achieve A Response To An Myc-Targeting Therapy Abandoned View
17767027 Molecular Signatures Of Radiation Sensitivity In Tumors, And Methods Of Use Thereof Abandoned View
17210737 Viral Detection Using Template Emulsification Patented View
17764717 Method Of Predicting Requirement For Biologic Therapy Abandoned View
17395149 Methods Of Assessing Breast Cancer Using Circulating Hormone Receptor Transcripts Abandoned View
17436117 Method Of Identifying Patients With Bortezomib Resistant Multiple Myeloma And Other Blood Diseases Abandoned View
17441047 Methods And Kits For Detecting Rhoa Mutations Abandoned View
18333231 Biomarkers For Bipolar Disorder And Schizophrenia Patented View
17813904 Methods, Treatment, And Compositions For Characterizing Thyroid Nodule Patented View
18493935 Genes And Gene Signatures For Diagnosis And Treatment Of Melanoma Patented View
18584709 Method Of Detecting Salmonella Typhimurium Patented View
17307607 Dna Adductomics By Mass Tag Prelabeling Patented View
18192922 Methods For The Epigenetic Analysis Of Dna, Particularly Cell-Free Dna Patented View
17253690 Systems And Methods For Determining A Treatment Course Of Action Patented View
17293493 New Methods For Species Identification Abandoned View
18939049 Methods Of Preparing Materials With Ammonia Oxidizing Bacteria And Testing Materials For Ammonia Oxidizing Bacteria Abandoned View
18157108 Methods For High-Throughput Labelling And Detection Of Biological Features In Situ Using Microscopy Patented View
18433029 Methods And Compositions For Determining Ph Abandoned View
17436163 Macrophage Markers In Cancer Abandoned View
17686895 Methods Of Administering 3,4-Diaminopyridine Abandoned View
17601332 Cancer Diagnostic Marker Using Transposase-Accessible Chromatin Sequencing Information About Individual, And Use Thereof Abandoned View
17395013 Systems And Methods Of Scoring Risk And Residual Disease From Passenger Mutations Abandoned View
17395033 Systems And Methods Of Assessing Breast Cancer Abandoned View
17434558 Sorting Cell-Type Specific Extracellular Vesicles Abandoned View
19023148 Ammonia Oxidizing Microorganisms For Use And Delivery To The Gastrointestinal System Abandoned View
18412907 Se33 Mutations Impacting Genotype Concordance Abandoned View
18829654 Ammonia Oxidizing Microorganisms For Use In Pest Control Abandoned View
17430873 Retrotransposon Biomarkers Abandoned View
18056967 Integration Of Tumor Characteristics With Breast Cancer Index Patented View
18763520 Ammonia Oxidizing Microorganisms For Use And Delivery To The Gastrointestinal System Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.